Traders should anticipate potential downward pressure on MBRX stock price as selling stockholders may begin offloading shares immediately. The 119% share overhang creates substantial near-term supply that could overwhelm demand, particularly given the company's small $13M market cap.
Price Chart
Executive Summary
Moleculin Biotech's S-3 shelf registration became effective on April 14, 2026, allowing selling stockholders to immediately resell up to 6,367,956 shares of common stock issued in a February 2026 warrant inducement offer. This resale potential represents approximately 119% of currently outstanding shares, creating a significant overhang that could pressure the stock price.
Key Facts
- S-3 shelf registration (File No. 333-294686) became effective April 14, 2026
- Registration covers resale of 6,367,956 shares by selling stockholders
- Shares were issued in February 2026 warrant inducement offer
- Resale shares represent approximately 119% of currently outstanding shares
- No proceeds to the company; shares are being sold by existing holders
Financial Impact
Potential dilution of 119% of outstanding shares through immediate resale by selling stockholders
Risk Factors
- Significant share dilution from immediate resale of 6.37M shares
- Downward pressure on stock price due to oversupply in the market
- Investor confidence erosion from large shareholder exit
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001181 |
| Document: 9999999995-26-001181-index.html | 9999999995-26-001181 |
| Document: 9999999995-26-001181.txt | 9999999995-26-001181 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $6.19 | awaiting T+20 | — | $7.09 (+14.46%) |
Oct 16, 2026 10d ago | 8-K | $0.2804 | awaiting T+20 | — | $7.09 (+2426.75%) |
Oct 9, 2026 16d ago | 8-K | $0.4139 | awaiting T+20 | — | $7.09 (+1611.77%) |
Oct 5, 2026 21d ago | 8-K | $0.4766 | awaiting T+20 | — | $7.09 (+1386.57%) |
Sep 29, 2026 27d ago | 8-K | $0.5264 | awaiting T+20 | — | $7.09 (+1245.93%) |
Sep 29, 2026 27d ago | Press Release | $0.5264 | awaiting T+20 | — | $7.09 (+1245.93%) |
Sep 28, 2026 28d ago | 8-K | $0.5690 | awaiting T+20 | — | $7.09 (+1145.17%) |
Sep 25, 2026 4w ago | 8-K | $0.6016 $6.50 | ▲ +980.45% | ▲ +981.93% | $7.09 (+1077.69%) |
Sep 23, 2026 4w ago | 8-K | $0.5279 $6.31 | ▲ +1095.30% | ▲ +1094.61% | $7.09 (+1242.11%) |
Sep 18, 2026 5w ago | 8-K | $0.5202 | awaiting T+20 | — | $7.09 (−1261.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers